Sign in to view content

Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial

Michael S. Ip, MD

Video
Published 2019

Michael S. Ip, MD

Diabetic Retinopathy Part I Symposium

Related

Progression of diabetic retinopathy in patients treated with 0.2 μg/day
Raymond Iezzi, MD, MS
Updates from the Field
2017
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Part 2: Telemedicine for Diabetic Retinopathy Screening
Jose Agustin Martinez, MD
On Demand Cases, Courses, and Papers
2017

Category: Diabetic Retinopathy

See more